T
Taiga Biotechnologies
Taiga Biotechnologies develops therapeutics for the treatment of hematological diseases and conditions
About Taiga Biotechnologies
Taiga Biotechnologies, Inc. is a clinical-stage biotechnology company dedicated to developing innovative treatments for solid tumors and infectious diseases. The company operates in the biopharmaceutical market, focusing on harnessing the power of the immune system to combat these diseases. Taiga Biotechnologies serves a diverse range of clients, including healthcare providers, research institutions, and pharmaceutical companies. Its business model revolves around the development and commercialization of proprietary therapies, particularly TBX 3400, which is currently undergoing clinical trials for melanoma, colorectal cancer, hepatitis B, and HPV. The company generates revenue through licensing agreements, partnerships, and potential future sales of its therapeutic products. Key features of their technology include no genetic modification, no expansion of cells, and a rapid 4-hour manufacturing process, making their treatments scalable, reliable, and low-risk.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Aug 2020 | $1.1M | — | Undisclosed | — |
| EARLY VCEquity / VC | May 2019 | $14M | $56M | Undisclosed | — |
Growth signals
Latest recorded traffic for Taiga Biotechnologies is 280 monthly website visits, up 154.5% over the last three months. Taiga Biotechnologies's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Taiga Biotechnologies in the Aurora ecosystem
The Taiga Biotechnologies office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Other known investors1 additional known investor
University of Colorado
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Taiga Biotechnologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Taiga Biotechnologies’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.










